Non-Cancer Clinical Trials

The multi-specialty research group supports research in:


  • No studies at this time


  • Ischemia: International Study of Comparative Health Effectiveness with Medical and Invasive Approaches
  • Artemis: Affordability and Real-World Anti Platelet Treatment Effectiveness after Myocardial Infarction Study (closed to enrollment)
  • CardioMEMS: Heart Failure System Post Approval Study


  • PERL: Preventing Early Renal Loss in Diabetes (Closed to enrollment)

Interventional Radiology

  • Attract: Acute Venous Thrombosis: Thrombus Removal with Adjunctive Catheter-Directed Thrombolysis (Closed to enrollment)
  • BEST Trial: Best Endovascular vs Best Surgical Therapy in Patients With Critical Limb Ischemia


  • No studies at this time


  • Crest-2: Carotid Revascularization and Medical Management for Aysymptomatic Carotid Stenosis Trial (Crest-2) Protocol
  • PRISMS (ML29093): A Phase IIIb, Double-Blind, Multicenter Study to Evaluate the Efficacy and Safety of Alteplase in Patients with Mild Stroke: Rapidly Improving Symptoms and Minor Neurologic Deficits (PRISMS)
  • Respect: Randomized, double-blind, evaluation in secondary stroke prevention comparing the Efficacy and safety of the oral Thrombin inhibitor dabigatran etexilate versus acetylsalicylic acid in patients with Embolic Stroke of Undetermined Course (RESPECT ESUS)
  • SMART study: A Prospective, Multicenter Study Assessing the Embolization of Neurovascular Lesions Using the Penumbra Smart Coil


  • Glaucoma: A Prospective, Randomized, Multi-Center, Open-Label Trial Comparing a Novel Goniotomy Procedure and an Ab Interno Trabecular Bypass Device in the Treatment of Mild to Moderate Glaucoma in Patients Undergoing Cataract Extraction


  • NAVIGATE: Clinical Evaluation of superDimension Navigation System for Electromagnetic Navigation Bronchoscopy (closed to enrollment)
  • Percepta: Prospective Registry to Evaluate Percepta Bronchial Genomic Classifier Patient Data: The PERCEPTA Registry


  • AWARE: Comparative and Pragmatic Study of Golimumab Intravenous (IV) (Simponi Aria) Versus Infliximab (Remicade) in Rheumatoid Arthritis (AWARE)
  • Axial Spondyloarthritis (AS0006): Phase 3, Multicenter, Randomized, Placebo-Controlled, Double-Blind Study to Evaluate the Efficacy and Safety of Certilozumab Pegol in Subjects with Active Axial Spondyloarthritis (AxSpa) without X-Ray Evidence of Ankylosing Spondylitis (AS) and Objective Signs of Inflammation
  • Lupus Nephritis (HGS1066-C1121): A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Belimumab plus Standard of Care versus Placebo plus Standard of Care in Adult Subjects with Active Lupus Nephritis
  • TULIP- A Multicentre, Randomised, Double-Blind, Placebo-Controlled, Phase 3 Study Evaluating the Efficacy and Safety of Anifrolumab in Adult Subjects with Active Systemic Lupus Erythematosus
  • Vectra- Prospective Outcomes Study: Vectra DA Guided Care Compared to Usual Care

Surgery Clinic

  • Linx PAS: A Post-Approval Study of the LINX Reflux Management System (Closed to enrollment)
  • AAA: Zenith® Low Profile AAA Endovascular Graft Clinical Study (closed to enrollment)
  • Caliber: Randomized Controlled Trial of LINX versus Double-Dose Proton Pump Inhibitor Therapy for Reflux Disease


  • Overactive Bladder: Study to Evaluate the Efficacy, Safety, and Tolerability of Mirabegron in Older Subjects With Overactive Bladder (OAB)

If you are interested in getting additional information on a research study, please contact:

Love + Medicine

Every day, Gundersen Health System delivers great medicine plus a little something extra—we call it Love + Medicine.

Share Your Story